Aspen Pharmacare
(OTC: APNHY)
|
2:15 PM UTC, 07/03/24 | |||
---|---|---|---|---|
Last: $12.55 | Change: +0.09 | %Change: +0.72% | Volume: 105 |
Open: | $ 12.55 | Volume: | 105 | |
---|---|---|---|---|
High: | $ 12.55 | Yield(%) | 1.02 | |
Low: | $ 12.55 | P/E Ratio (ttm): | 20.81 | |
Dividend ($): | 0.13 | Market Cap ($): | 5.49B | |
EPS ($) | n/a | Shares Out: | 444.24M |
% Price Change (last 4 weeks): | -1.62 |
---|---|
% Price Change (last 13 weeks): | 5.76 |
% Price Change (last 26 weeks): | 14.09 |
% Price Change (last 52 weeks): | 26.19 |
% Price Change (year to date): | 11.07 |
Return on Equity (%): | 6.61 |
---|---|
Return on Assets (%): | 4.23 |
Return on Invested Capital (%): | 6.22 |
Gross Profit Margin (%): | 44.59 |
---|---|
Net Profit Margin (%): | 12.84 |
Operating Profit Margin (%): | 22.03 |
|
|
50-day Moving Average: | $6.11 |
---|---|
200-day Moving Average: | $3.71 |
Avg. Daily Vol. (last 50 days): | 382 |
Avg. Daily Vol. (last 200 days): | 268 |
52-wk high: | $13.44 |
52-wk low: | $8.35 |
Bid: | $n/a |
Ask: | $n/a |
Aspen Pharmacare Holdings Ltd. manufactures and supplies branded and generic pharmaceutical products. It operates through the Commercial Pharmaceuticals and Manufacturing segments. The Commercial Pharmaceuticals segment consists of the following business sub segments: Sterile Focused Brands, which includes the Anaesthetics and Thrombosis portfolios; and Regional Brands, which are products that are managed on a regional basis. The Manufacturing segment focuses on the following business sub segments: Active Pharmaceutical Ingredients, which involved in API Chemicals business and non-heparin biochemical API business; Heparin, which refers to the full value chain contribution from all heparin containing products; FDF Steriles, which includes all FDF sterile sales; and FDF Other, which consists of all non-sterile FDF products. The company was founded by Michael Guy Attridge and Stephen Bradley Saad in 1850 and is headquartered in Durban, South Africa.
|
Aspen Pharmacare
Aspen Place, 9 Rydall Vale Park Douglas Saunders Drive La Lucia Ridge Durban NL 4019 Phone: 27.31.580.8600 Fax: n/a http://www.aspenpharma.com |
Earnings (1year) ($): | 0.59 |
---|---|
Annual Dividend ($): | 0.13 |
Current P/E Ratio (ttm): | 20.81 |
Book Value ($): | 10.28 |
Cash Flow ($): | 0.89 |
Price/Earnings (x): | 20.81 |
---|---|
Price/Sales (x): | 1.88 |
Price/Book (x): | 0.95 |
Price/Cash Flow (x): | 13.90 |
Quick Ratio (x): | 1.08 |
---|---|
Current Ratio (x): | 1.92 |
LT Debt/Equity (x): | 24.79 |
Total Debt/Equity (x): | 33.96 |